Caliway Biopharmaceuticals Co., Ltd.
Clinical trials sponsored by Caliway Biopharmaceuticals Co., Ltd., explained in plain language.
-
Belly fat melting shot? phase 3 trial begins.
Disease control Not yet recruitingThis Phase 3 trial tests whether an injection called CBL-514 can safely reduce abdominal fat. 300 adults with moderate to severe belly fat will receive either the drug or a placebo. The study measures fat loss by MRI and patient ratings over time.
Phase: PHASE3 • Sponsor: Caliway Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New injection melts belly fat in clinical trial
Symptom relief Not yet recruitingThis study tests an injection called CBL-514 to see if it can safely reduce belly fat. About 250 adults with extra abdominal fat will receive either the injection or a placebo. The goal is to measure fat loss using MRI and doctor ratings.
Phase: PHASE2 • Sponsor: Caliway Biopharmaceuticals Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New shot aims to melt belly fat without surgery
Symptom relief Not yet recruitingThis phase 3 trial tests an injection called CBL-514 to see if it can safely reduce belly fat. About 320 adults with moderate to severe abdominal fat will receive either the drug or a placebo. The main goal is to see if more people in the drug group report a meaningful fat reduct…
Phase: PHASE3 • Sponsor: Caliway Biopharmaceuticals Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC